Skip to main content

barr 20 mg 1077 (Temozolomide 20 mg)

Pill with imprint barr 20 mg 1077 is White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 20 mg 1077

Temozolomide

Imprint
barr 20 mg 1077
Strength
20 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-7600 (Discontinued)
Inactive Ingredients
lactose anhydrous, silicon dioxide, povidone k30, sodium starch glycolate type A potato, stearic acid, tartaric acid, D&C Yellow No. 10, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, titanium dioxide, ammonia, ferrosoferric oxide, propylene glycol, ferric oxide red, shellac, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.